Navigation Links
DVT Awareness Survey Findings for Respondents in High-Risk Groups:,Obese Individuals

WASHINGTON, March 15, 2007 /PRNewswire/ -- Up to two million Americans are affected each year by DVT, with up to 600,000 hospitalized. Its primary complication, pulmonary embolism (PE), claims up to 300,000 lives annually -- more than breast cancer and AIDS combined.

The Coalition to Prevent Deep-Vein Thrombosis (DVT) recently sponsored an online survey of a nationally representative sample of consumers and physicians. The survey, which was conducted by Penn, Schoen & Berland Associates, assessed what Americans know about DVT.

Obesity is defined by the National Institutes of Health as having a Body Mass Index greater than 30 (approximately 30 pounds or more overweight). Abdominal obesity may not only promote blood clotting, but also impair the body's natural ability to dissolve clots.

The survey results point to an ongoing need for patients and physicians alike to know more about this leading cause of death and how they can reduce the risk of DVT. Following are the results specific to obesity.

Most physicians do not recognize obesity as a significant risk factor for DVT and are unlikely to initiate DVT therapy in obese patients.

    * When probed, less than four in 10 (38%) rate obesity as a very

      significant risk factor for DVT.

    * Less than a quarter (14%) strongly agree that they are likely to

      initiate DVT treatment as a first step in an obese patient who does not

      have other risk factors.

Obese individuals are slightly less likely than the general population to have discussed DVT with their physician.

    * 7% of the 210 obese individuals surveyed say their primary care

      physician has discussed DVT with them, compared with 12% of the general

      population.

    * Obese individuals are as likely to get their information about DVT from

      an advertisement as from a doctor, nurse or other medical professional

 
     (20% for each).

Although most obese individuals can name some risk factors for DVT, very few recognize obesity as a risk factor.

    * Top of mind, 68% of obese individuals are able to identify at least one

      risk factor for DVT.

    * Less than one in 10 (9%) name weight factors/obesity as a common risk

      factor for DVT.

Obese individuals know somewhat less about DVT than the general population and are slightly less likely to seek information about it.

    * 42% of obese individuals have some knowledge about DVT, vs. 51% of the

      general population.

    * 10% have actively sought information about DVT, compared with 15% of the

      general population.

The Coalition to Prevent Deep-Vein Thrombosis is funded by sanofi-aventis U.S. LLC

US.ENO.07.01.121

CONTACT: Shannon C. McIntyre, +1-212-614-4351, shannon.mcintyre@bm.com

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Survey Reveals Significant Public Lack of Diabetes Awareness
2. DVT Awareness Survey Findings: Heart and Respiratory Patients
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
5. Waismann Method Survey Reveals Dependency Risk for People Using Suboxone
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
8. New Survey Finds Troubling Data on American Asthma Sufferers
9. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
10. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
11. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... Clara, CA (PRWEB) , ... April 28, 2017 ... ... is pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep ... user experience, since it streamlines the reporting process and provides a familiar interface ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, ... the GlycoMark test throughout the Northeast U.S. , GlycoMark is the only ... The GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic ...
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
Breaking Medicine News(10 mins):